PREGABALIN 75mg. IP + DULOXETINE 20mg. IP

A combinational therapy that treats patients with painful neuropathies of any cause. A first-line pharmaceutical agent for moderate to severe painful neuropathy conditions. (Hiroyuki Enomoto, 2018) Successfully alleviates the symptoms of various types of neuropathic pain. (Vivek Verma, 2014) Reduces excitatory neurotransmitters release and inhibits synaptic transmission. (Vivek Verma, 2014) Shows significant improvement in functional outcomes in patients with diabetic peripheral neuropathic pain. (David G Armstrong, 2007) A well-tolerated and effective agent for the treatment of painful diabetic neuropathy and fibromyalgia. (Asquad Sultan, 2008) A valuable treatment option for clinicians and patients to assist with the management of diabetic peripheral neuropathic pain. (Daniel K Kajdasz, 2007) Significantly reduces pain intensity and improves health-related quality of life of patients with fibromyalgia. (Masato Murakami, 2015) Shows an improvement in multiple clinical outcomes in patients with fibromyalgia than monotherapy. (Ian Gilron, 2016)